ADI 2016 | Disease-modifying therapy for dementia: Challenges with early detection at pre-dementia stage

At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Anders Wimo MD, PhD, from Karolinska Institutet, Stockholm, Sweden, explains the challenges of the development of disease-modifying therapies to intervene during the earliest stages of dementia.